DR. RUBAB GINWALA

Dr. SAPAN SHAH, Dr.Satani Dipali Rameshchandra

Abstract

Aim- To evaluate the role of intralesional bleomycin injection for treatment of orbital lymphangiomas.

Methods- This was a prospective interventional study of 2 patients diagnosed with orbital lymphangioma who received intralesional bleomycin injection at a dose of 0.5mg/kg body weight(maximum 15mg) along with lignocaine 2% as seen under ultrasound guidance in deeper lesions.

Results- Proptosis and lid swelling were the presentations. Both patients showed complete resolution as evidenced radiologically and on digital photography. None of the patients had recurrence.

Conclusion- No significant ophthalmic or systemic side effect was noticed in our study group. Therefore intralesional bleomycin injection can be considered 1st line therapy fot treatment of orbital lymphangioma.